Tripartite motif-containing protein 5 alpha (TRIM5α)

TRIM5α is a cytosolic antiviral restriction factor of the tripartite motif (TRIM) protein family, notable for its species-specific suppression of retrovirus infection, especially HIV and related lentiviruses. It contains a canonical RBCC motif comprising a RING E3 ligase domain, a B-box2 domain (responsible for oligomerization), and a coiled-coil domain (facilitating dimerization and lattice formation), followed by a C-terminal SPRY/B30.2 domain that directly recognizes retroviral capsids[3][6][1][4][5][8]. Upon binding to viral capsids, TRIM5α self-assembles into hexagonal lattices encaging the capsid, disrupting viral uncoating, inhibiting reverse transcription, and recruiting ubiquitin for proteasomal degradation[1][5][8]. TRIM5α also acts as a pattern recognition receptor, activating inflammatory signaling cascades (notably NF-κB and AP1) in an autophagy-dependent manner[2]. Its restriction specificity is determined by sequence variation within its SPRY domain, with codon 332 being critical for HIV-1 recognition in primates[4]. As an essential component of intrinsic immunity, TRIM5α is a key modulator of host–virus interactions and is under strong evolutionary pressure in primate populations[4][6].

Other names

TRIM5TRIM5αTripartite motif protein 5 alpha

Drugs targeting or modulating TRIM5α would aim to: - Enhance viral capsid recognition or restriction - Boost proteasomal degradation of viral proteins - Activate cellular antiviral signaling pathways (NF-κB, AP1)